Introduction
Mycobacterium tuberculosis, the aetiological agent of tuberculosis (TB), remains a major health burden globally, resulting in approximately 1.4 million deaths annually (World Health Organization, 2013) . The emergence of drug-resistant strains underlines the urgent need for the development of new anti-mycobacterial therapeutics. Multiple drug resistant strains of TB (MDR-TB), and more recently extensively drug-resistant strains of TB (XDR-TB), are classified as expressing resistance to at least two of the first-line anti-TB drugs and a number of second-line anti-TB drugs, resulting in a limited means of treating diseased patients.
The key first-line drug in TB treatment is isoniazid (INH), a hydrazide prodrug activated by the catalase-peroxidase KatG to produce INH-NAD(P) adducts that exhibit potent anti-mycobacterial activity (Rozwarski et al., 1998; Timmins & Deretic, 2006) . The primary target of the INH-NAD(P) adduct is InhA, an enoylacyl carrier protein reductase that plays an essential role in mycolic acid biosynthesis (Dessen et al., 1995) . In addition to InhA, the drug acts against 17 recently identified targets within M. tuberculosis (Argyrou et al., 2006) . These targets exhibit a variety of essential roles implemented in the fitness and survival of the mycobacterium, and provide a variety of potential candidates for the development of new anti-TB therapeutics.
One of the targets identified is the essential aldo-keto reductase (AKR) AKR5H1 encoded by the gene rv2971. rv2971 has previously been characterized as an essential gene for growth and survival in M. tuberculosis (Sassetti et al., 2003) with a potential role in the detoxification of toxic metabolites (Grimshaw, 1992; Grant et al., 2003; Penning & Drury, 2007) . Recently, the catalytic activity of Rv2971 and its M. smegmatis orthologue MSMEG_2407 (67% sequence identity) has been characterized, revealing differences in dicarbonyl substrate specificities and affinities (Scoble et al., 2010) . The potency of INH was characterized against both enzymes, revealing a higher affinity against MSMEG_2407 compared with Rv2971, with apparent K i values of 6.0 AE 1.2 and 31.0 AE 1.4 mM reported, respectively (Scoble et al., 2010) .
To gain functional insight into the role of AKR5H1, the crystal structure of MSMEG_2407 has been determined in its apo form and in its holoenzyme form in the presence of NADPH (Scoble et al., 2010) . The crystal structure reveals an (/) 8 -barrel topology, or a TIM-barrel fold, typical of other AKRs as previously described (Banner et al., 1975) , and enabled residues essential for enzyme kinetic activity and cofactor binding to be ascertained. While the crystal structure of MSMEG_2407 provides invaluable information on its functionality, Rv2971 possesses a number of differences in these binding pockets.
Here, we determined the crystal structure of Rv2971 in its unliganded form to a resolution of 1.60 Å . The structure enables the characterization of the substrate and NADPH binding pockets, revealing the subtle architectural differences between Rv2971 and MSMEG_2407, and providing insight into the differences in substrate specificities and INH inhibition levels. In addition, the Rv2971 structure may provide an initial template for the development of new anti-mycobacterial therapeutics.
Materials and methods

Cloning, expression and purification of recombinant protein
The gene encoding Rv2971 was cloned, overexpressed and purified as soluble recombinant protein as previously described (Scoble et al., 2010) . For crystallization experiments, the purified recombinant protein was buffer-exchanged into 10 mM Tris-HCl pH 8.0, 200 mM NaCl and concentrated to 7 mg ml À1 . The concentration of purified Rv2971 was determined spectrophotometrically (NanoDrop 1000, Thermo Scientific) at 280 nm and was calculated using an extinction coefficient of 28 545 M À1 cm À1 . The molecular weight, purity and identity of the protein were confirmed by SDS-PAGE and Western blotting with anti-hexahistidine antibody (R&D Systems).
Crystallization
The initial crystallization experiments involved screening 192 conditions from commercially available kits from Hampton Research (Crystal Screen HT and PEG/Ion HT) using a CrystalMation (Rigaku) integrated robotic workstation and the sitting-drop vapourdiffusion technique. Rod-shaped crystals were obtained initially at a structural communications Acta Cryst. 
is the scaled intensity of the ith measurement and hI(hkl)i is the mean intensity for that reflection. R p.i.m. = R merge divided by the multiplicity. § R work = P hkl jF obs j À jF calc j = P hkl jF obs j for all data excluding the 5% that comprise the R free used for crossvalidation. } Root-mean-square deviation from ideal values (Engh & Huber, 1991) . protein concentration of 7 mg ml À1 at 277 K after 24 h of equilibration against a crystallization condition comprised of 0.2 M sodium malonate pH 5.0, 20%(w/v) polyethylene glycol (PEG) 3350. Larger crystals of high diffraction quality were obtained by optimizing the crystal condition in 24-well Linbro plates (Hampton Research). The crystallization condition was optimized by fine-tuning the pH, protein concentration and precipitant concentration using a hanging drop consisting of 1 ml protein solution and 1 ml precipitant solution and a 500 ml reservoir volume (Fig. 1a) . The best crystals appeared after 24 h of equilibration against a crystallization condition comprised of 0.2 M sodium malonate pH 5.0, 19%(w/v) PEG 3350 at a protein concentration of 7 mg ml À1 and grew to full size in 2 d.
X-ray data collection
For X-ray diffraction data collection, crystals of Rv2971 were transferred to a CryoLoop and soaked in a cryoprotectant consisting of 19%(v/v) PEG 3350, 0.2 M sodium malonate pH 5.0, 15%(w/v) glycerol before cooling to 100 K in a nitrogen-gas stream. A complete data set was collected from a single crystal on the MX2 beamline at the Australian Synchrotron using an ADSC Quantum 315rr CCD detector. A total of 360 frames of 0.5 were recorded with an exposure time of 1 s per frame (Fig. 1b) . The data were processed using iMosflm (Battye et al., 2011) and various programs from the CCP4 suite such as SCALA and POINTLESS (Winn et al., 2011) . The final statistics of data collection and processing are summarized in Table 1 .
Structural determination
The crystal structure of Rv2971 was determined by the molecularreplacement method with Phaser-MR as part of the PHENIX program suite (Adams et al., 2010) . The coordinates of M. smegmatis AKR5H1 MSMEG_2407 (67% sequence identity; PDB entry 2wzm; Scoble et al., 2010) were used as the search model. The resultant LLG score and TZF score obtained were 2010.15 and 43.8, respectively. For cross-validation, a random set of 5% of the total reflections were kept aside from the refinement and used for the calculation of R free (Brü nger, 1992 ). The initial model was refined as a rigid body followed by TLS refinement using TLS groups as suggested by the TLSMD server (Painter & Merritt, 2006) . The TLS refinement was performed according to four TLS groups, which are A8-A171, A172-A188, A189-A257 and A258-A283. The model obtained was manually adjusted using the interactive graphics program Coot (Emsley et al., 2010) and refined using phenix.refine (Adams et al., 2010) until no further improvement of the model could be made. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4otk. The final statistics of structural refinement are summarized in Table 1 .
Structural analysis
Refinement validation was conducted using MolProbity and the POLYGON tools in the PHENIX program suite (Adams et al., 2010; Chen et al., 2010) . Secondary structure was confirmed by the STRIDE plugin in PyMOL (Zhu, 2011) . All structural superpositions were achieved using the SSM superpose feature of Coot (Emsley et al., 2010) . Electrostatic surface distribution calculations were performed using the APBS plugin for PyMOL (Baker et al., 2001) . The M. smegmatis AKRH5 MSMEG_2407 holoenzyme crystal structure (PDB entry 2wzm) and the apo crystal structure (PDB entry 2wzt; Scoble et al., 2010) were used for structural alignments.
Results and discussion
Structural determination of Rv2971
To gain structural insight into the isoniazid drug target Rv2971, the crystal structure of the M. tuberculosis protein was determined. Recombinant M. tuberculosis Rv2971 was expressed, purified and crystallized using vapour-diffusion methods (Fig. 1a ). Rv2971 was purified as a monomer as determined by size-exclusion chromatography, and routinely produced yields of 2 mg of pure protein per litre. Crystals belonged to the trigonal space group P3 2 21, with unitcell parameters a = b = c = 86.3 Å , = = 90.0 , = 120.0 . A complete data set was collected to a resolution of 1.60 Å from a single crystal at 100 K (Fig. 1b) , with data collection and processing summarized in Table 1 Acta Cryst. (2014). F70, 572-577
Figure 2
Overall crystal structure of Rv2971. Cartoon representation of the (a) top view and (b) side view rotated 90 of the overall structure. The C-and N-termini of the structure are labelled, with secondary-structure elements -strands, -helices and 3 10 -helices, as calculated by STRIDE (Zhu, 2011) , coloured magenta, blue and cyan, respectively. All figures were prepared in PyMOL. modated in the asymmetric unit, with a calculated V M value of 3.07 Å 3 Da À1 (Matthews, 1968) .
The crystal structure of Rv2971 was determined to 1.60 Å resolution via molecular replacement using the M. smegmatis orthologue, MSMEG_2407, as a search model (PDB entry 2wzm), with final R work and R free statistics of 13.90 and 16.90%, respectively. Refinement statistics are summarized in Table 1 . Of the construct utilized in crystallization, the large vector-derived N-terminal domain (MGSSH6SSGLVPRGSHMASMTGGQQMGRGSEF) was unstructured and residues 7-282 of Rv2971 were modelled into the electron density. The final model consisted of 276 amino-acid residues and 311 water molecules. The final model also included two malonate ions and two chloride ions originating from the crystallization condition and crystallization buffer, respectively. A Ramachandran plot analysis of the final model by C geometry validation (Lovell et al., 2003) showed that 98.2% of the residues are in the most favoured regions, while 1.8% of residues are within the allowed regions.
Overall crystal structure of Rv2971
The overall 1.60 Å resolution crystal structure of Rv2971 in its unliganded form ( Figs. 2a and 2b) adopts an (/) 8 -barrel topology, or a TIM-barrel fold, as previously described (Banner et al., 1975) . Rv2971 substrate and cofactor binding pocket architecture. Cartoon representation of (a) the substrate binding pocket and (b) the NADPH binding pocket. Two malonate ions and a single chloride ion bound during crystallization are represented as cyan sticks and magenta spheres, respectively. Electron density of maps is shown as F o À F c simulated-annealing OMIT maps contoured at 3. Amino-acid residues involved in binding to the malonate and chloride ions are represented as green sticks. Hydrogenbond formation between contact residues and ions is represented as black dashes, with bond distances ranging between 2.6 and 3.6 Å . The Asp52-Tyr57-Lys82-His115 catalytic tetrad is represented in wheat. The solvent-accessible surface representation coloured by electrostatic potential of the (c) substrate binding pocket and (d) NADPH binding pocket was calculated by APBS (Baker et al., 2001) . The potential contours are shown on a scale from +5.0 (blue) to À5.0 k B T e À1 (red); white indicates a value close to 0 k B T e À1 . Indicated are the positions of the Asp52-Tyr57-Lys82-His115 catalytic tetrad.
where the TIM barrel is comprised of eight -strands (1-8), flanked by eight -helices (1-8) interwoven in an antiparallel manner between each -strand. Situated at the N-terminus of the structure are two antiparallel -stands (A and B) that cover the base of the protein structure (Fig. 2b) . The TIM-barrel structure is punctuated by two -helices (A and B) on the C-terminal side of the protein structure ( Fig. 2a) . Dispersed through the C-terminal side, or 'open rim' face, of the protein structure are a series of 3 10 -helices (h1, h3, h4 and hA) that contribute to the overall -helical content of the Rv2971 structure by forming the NADPH binding pocket.
Substrate and NADPH binding pockets of Rv2971
The crystal structure of Rv2971 was determined in the presence of two malonate ions bound within the substrate binding pocket and NADPH binding pocket. Attempts to soak NADPH into the crystals were unsuccessful because of the presence of the malonate ions blocking the binding pockets. Within the substrate binding pocket, the malonate ion is bound to Rv2971 via hydrogen bonding with Asp52 and His115 at a bond distance of 2.6 and 2.9 Å , respectively ( Fig. 3a) . Residues Asp52 and His115 belong to the Asp-Tyr-Lys-His catalytic tetrad typical of AKRs. In the case of Rv2971, the catalytic tetrad is comprised of residues Asp52-Tyr57-Lys82-His115. A single chloride ion is bound between the substrate and NADPH binding pockets, and is bound to residue Leu197 via hydrogen bonding (Fig.  3b) . A second malonate ion is bound within the NADPH pocket, binding residues involved in contacts with NADPH via hydrogenbond formation, with bond distances ranging between 3.0 and 3.6 Å (Fig. 3b ). Both the substrate and NADPH binding pockets are electrostatically positively charged (Figs. 3c and 3d ) which, as well as being highly surface exposed, facilitates the substrate and NADPH binding capabilities of Rv2971.
Structural comparison with the M. smegmatis orthologue MSMEG_2407
With the successful determination of the crystal structure of Rv2971, a structural comparison was conducted with MSMEG_2407 to characterize the previously observed differences in enzyme kinetic activity (Scoble et al., 2010) . The crystal structures of Rv2971 and the structural communications 576 Shahine et al. Rv2971
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